EUR 76.5
(1.8%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 5.79 Billion EUR | 1.99% |
2022 | 5.67 Billion EUR | -16.9% |
2021 | 6.83 Billion EUR | 4.56% |
2020 | 6.53 Billion EUR | 25.97% |
2019 | 5.18 Billion EUR | 8.76% |
2018 | 4.76 Billion EUR | 1.0% |
2017 | 4.72 Billion EUR | -1.86% |
2016 | 4.81 Billion EUR | 76.44% |
2015 | 2.72 Billion EUR | 21.4% |
2014 | 2.24 Billion EUR | 12.96% |
2013 | 1.98 Billion EUR | -4.55% |
2012 | 2.08 Billion EUR | 4.17% |
2011 | 2 Billion EUR | 40.41% |
2010 | 1.42 Billion EUR | -1.78% |
2009 | 1.45 Billion EUR | -18.72% |
2008 | 1.78 Billion EUR | 12.96% |
2007 | 1.57 Billion EUR | 20.75% |
2006 | 1.3 Billion EUR | 3.32% |
2005 | 1.26 Billion EUR | 15.95% |
2004 | 1.09 Billion EUR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 5.45 Billion EUR | 0.0% |
2023 Q2 | 5.35 Billion EUR | 0.0% |
2023 Q4 | 5.79 Billion EUR | 0.0% |
2023 FY | 5.79 Billion EUR | 1.99% |
2022 FY | 5.67 Billion EUR | -16.9% |
2022 Q2 | 6.58 Billion EUR | 0.0% |
2022 Q4 | 5.67 Billion EUR | 0.0% |
2021 Q2 | 6.32 Billion EUR | 0.0% |
2021 FY | 6.83 Billion EUR | 4.56% |
2021 Q4 | 6.83 Billion EUR | 0.0% |
2020 FY | 6.53 Billion EUR | 25.97% |
2020 Q2 | 5.92 Billion EUR | 0.0% |
2020 Q4 | 6.53 Billion EUR | 0.0% |
2019 Q2 | 5.17 Billion EUR | 0.0% |
2019 FY | 5.18 Billion EUR | 8.76% |
2019 Q4 | 5.18 Billion EUR | 0.0% |
2018 Q4 | 4.76 Billion EUR | 0.0% |
2018 FY | 4.76 Billion EUR | 1.0% |
2018 Q2 | 4.43 Billion EUR | 0.0% |
2017 Q4 | 4.72 Billion EUR | 0.0% |
2017 Q2 | 4.85 Billion EUR | 0.0% |
2017 FY | 4.72 Billion EUR | -1.86% |
2016 FY | 4.81 Billion EUR | 76.44% |
2016 Q2 | 2.35 Billion EUR | 0.0% |
2016 Q4 | 4.81 Billion EUR | 0.0% |
2015 Q4 | 2.72 Billion EUR | 0.0% |
2015 FY | 2.72 Billion EUR | 21.4% |
2015 Q2 | 2.11 Billion EUR | 0.0% |
2014 FY | 2.24 Billion EUR | 12.96% |
2014 Q2 | 1.93 Billion EUR | 0.0% |
2014 Q4 | 2.24 Billion EUR | 0.0% |
2013 Q2 | 1.95 Billion EUR | 0.0% |
2013 Q4 | 1.98 Billion EUR | 0.0% |
2013 FY | 1.98 Billion EUR | -4.55% |
2012 Q3 | 520.95 Million EUR | -70.54% |
2012 Q2 | 1.76 Billion EUR | 239.44% |
2012 Q1 | 520.95 Million EUR | -73.96% |
2012 FY | 2.08 Billion EUR | 4.17% |
2012 Q4 | 2.08 Billion EUR | 300.0% |
2011 Q4 | 2 Billion EUR | 300.0% |
2011 Q1 | 500.1 Million EUR | -64.9% |
2011 Q2 | 1.63 Billion EUR | 227.91% |
2011 FY | 2 Billion EUR | 40.41% |
2011 Q3 | 500.1 Million EUR | -69.5% |
2010 Q3 | 356.17 Million EUR | -73.02% |
2010 Q1 | 356.17 Million EUR | -75.44% |
2010 FY | 1.42 Billion EUR | -1.78% |
2010 Q2 | 1.32 Billion EUR | 270.63% |
2010 Q4 | 1.42 Billion EUR | 300.0% |
2009 Q3 | 362.62 Million EUR | 0.0% |
2009 Q2 | 362.62 Million EUR | 0.0% |
2009 Q1 | 362.62 Million EUR | -18.72% |
2009 FY | 1.45 Billion EUR | -18.72% |
2009 Q4 | 1.45 Billion EUR | 300.0% |
2008 Q1 | 446.15 Million EUR | 12.96% |
2008 Q4 | 446.15 Million EUR | 0.0% |
2008 Q3 | 446.15 Million EUR | 0.0% |
2008 FY | 1.78 Billion EUR | 12.96% |
2008 Q2 | 446.15 Million EUR | 0.0% |
2007 Q2 | 394.95 Million EUR | 0.0% |
2007 Q1 | 394.95 Million EUR | 20.75% |
2007 FY | 1.57 Billion EUR | 20.75% |
2007 Q3 | 394.95 Million EUR | 0.0% |
2007 Q4 | 394.95 Million EUR | 0.0% |
2006 Q2 | 327.07 Million EUR | 0.0% |
2006 Q3 | 327.07 Million EUR | 0.0% |
2006 FY | 1.3 Billion EUR | 3.32% |
2006 Q4 | 327.07 Million EUR | 0.0% |
2006 Q1 | 327.07 Million EUR | 3.32% |
2005 Q2 | 316.57 Million EUR | 0.0% |
2005 Q3 | 316.57 Million EUR | 0.0% |
2005 FY | 1.26 Billion EUR | 15.95% |
2005 Q1 | 316.57 Million EUR | 15.95% |
2005 Q4 | 316.57 Million EUR | 0.0% |
2004 Q1 | 273.02 Million EUR | 0.0% |
2004 Q2 | 273.02 Million EUR | 0.0% |
2004 Q3 | 273.02 Million EUR | 0.0% |
2004 Q4 | 273.02 Million EUR | 0.0% |
2004 FY | 1.09 Billion EUR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Miliboo Société anonyme | 11.92 Million EUR | -48452.268% |
Neolife SA | 3.04 Million EUR | -190128.387% |
U10 Corp | 79.48 Million EUR | -7187.116% |
Roche Bobois S.A. | 346.17 Million EUR | -1573.089% |
Vista Alegre Atlantis, SGPS, S.A. | 160.41 Million EUR | -3510.443% |